Autor: |
Elias ML; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA., Koptyev J; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA., Yan BY; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA., Strunk A; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA., Sharon VR, Garg A; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA. |
Jazyk: |
angličtina |
Zdroj: |
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Aug 25; Vol. 48 (9), pp. 1044-1046. |
DOI: |
10.1093/ced/llad155 |
Abstrakt: |
Competing Interests: Conflicts of interest: A.G. reports personal fees from AbbVie, Aclaris Therapeutics, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, InflaRx, Insmed, Janssen, Novartis, Pfizer, UCB, Union Therapeutics and Viela Biosciences, and receives honoraria. A.G. receives research grants from AbbVie, UCB and National Psoriasis Foundation. He is co-copyright holder of the Hidradenitis Suppurativa Quality of Life (HiSQOL) scale, and Investigator’s Global Assessment and Patient’s Global Assessment instruments for hidradenitis suppurativa |
Databáze: |
MEDLINE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|